LKM1 appearance in a HLA-DR3+ patient with chronic hepatitis C during interferon treatment

First-line therapies for H. pylori infection in Italy: a pooled-data analysis.

Acta gastro-enterologica Belgica·2022

Mesh repair for lateral inguinal hernias: a non-evidence-based practice.

Hernia : the journal of hernias and abdominal wall surgery·2021

Not all abolished lung sliding are pneumothorax: the case of a particular lung atelectasis.

Journal of ultrasound·2020

Delayed hypersensitivity to new oral anticoagulants. Demonstration of cross reactivity for the drug category and definition of non-irritant concentrations for patch tests.

European annals of allergy and clinical immunology·2018

Type 1 and type 2 autoimmune hepatitis in adults share the same clinical phenotype.

Alimentary pharmacology & therapeutics·2015

Risk of desmoid tumours after open and laparoscopic colectomy in patients with familial adenomatous polyposis.

The British journal of surgery·2014

Systemic therapy for HCC: Doublets, triplets and beyond.

Journal of hepatology·2026

Integrating systemic therapy in the earlier stages of liver cancer.

Journal of hepatology·2026

The use of locoregional therapies in cholangiocarcinoma.

Journal of hepatology·2026

Liver transplantation for primary liver cancers in the era of transplant oncology.

Journal of hepatology·2026

Advances in the imaging of liver cancer.

Journal of hepatology·2026

Mouse models of acute and chronic hepatitis E virus infection.

Journal of hepatology·2026

[Hybrid medicine in the 21st century (Part 1)].

Revue medicale suisse·2026

Peptide-Enabled Nanoplatforms for Malaria and Leishmaniasis: From Intracellular Targeting to Translational Diagnostic Perspectives.

ChemMedChem·2026

Operationalizing Alzheimer's disease trials in the era of targeted therapies.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026

Quercetin-Based Nanotherapeutics for Targeted Drug Delivery in Alzheimer's Disease: Comparative Insights into Molecular Mechanisms, Blood-Brain Barrier Targeting and Therapeutic Perspectives.

Molecular neurobiology·2026

Mutational constraints on RSV F and its neutralization by antibodies.

Nature·2026

Identifying General Practitioners, Nurses, and Pharmacists Training Needs in Precision Medicine: A Survey Study.

The Journal of continuing education in the health professions·2026

Related Experiment Videos

LKM1 appearance in a HLA-DR3+ patient with chronic hepatitis C during interferon treatment

Related Concept Videos

First-line therapies for H. pylori infection in Italy: a pooled-data analysis.

Mesh repair for lateral inguinal hernias: a non-evidence-based practice.

Not all abolished lung sliding are pneumothorax: the case of a particular lung atelectasis.

Delayed hypersensitivity to new oral anticoagulants. Demonstration of cross reactivity for the drug category and definition of non-irritant concentrations for patch tests.

Type 1 and type 2 autoimmune hepatitis in adults share the same clinical phenotype.

Risk of desmoid tumours after open and laparoscopic colectomy in patients with familial adenomatous polyposis.

Systemic therapy for HCC: Doublets, triplets and beyond.

Integrating systemic therapy in the earlier stages of liver cancer.

The use of locoregional therapies in cholangiocarcinoma.

Liver transplantation for primary liver cancers in the era of transplant oncology.

Advances in the imaging of liver cancer.

Mouse models of acute and chronic hepatitis E virus infection.

[Hybrid medicine in the 21st century (Part 1)].

Peptide-Enabled Nanoplatforms for Malaria and Leishmaniasis: From Intracellular Targeting to Translational Diagnostic Perspectives.

Operationalizing Alzheimer's disease trials in the era of targeted therapies.

Quercetin-Based Nanotherapeutics for Targeted Drug Delivery in Alzheimer's Disease: Comparative Insights into Molecular Mechanisms, Blood-Brain Barrier Targeting and Therapeutic Perspectives.

Mutational constraints on RSV F and its neutralization by antibodies.

Identifying General Practitioners, Nurses, and Pharmacists Training Needs in Precision Medicine: A Survey Study.

Related Experiment Videos

LKM1 appearance in a HLA-DR3+ patient with chronic hepatitis C during interferon treatment

Related Concept Videos

Related Articles